Trial intelligence / Profile preview

Clinical study to evaluate Denutraxan for relief of pruritus associated with atopic dermatitis in children

2010-021568-14Phase 3Active

Sponsor
ISDIN
Start
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of pramoxine in atopic dermatitis (AD) and pruritus, sponsored by ISDIN. Primary endpoint: Change in pruritus intensity from baseline to end of study (pediatric VAS). Started Jul 2010; status: active.

02

Drugs

pramoxine
03

Conditions

atopic dermatitis (AD)pruritus

Beyond the preview

Go deeper on 2010-021568-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021568-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call